16:30 EDT Athira Pharma trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATHA:
- Athira says clinical trial of fosgonimeton for AD primary endpoint not met
- Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease
- Athira Pharma trading halted, news pending
- Athira Pharma initiated with a Buy at Rodman & Renshaw
- ATHA Earnings this Week: How Will it Perform?